Switch theme
Sign up to access all valuation multiples
Tsuruha Holdings Inc manages pharmaceutical companies in Japan, where the drugstore business is the core of their operations. The company generates revenue through selling prescription and over-the-counter drugs, medical supplies, nursing care products, discount cosmetics, health products, and a miscellaneous assortment of general merchandise. Tsuruha also provides blood testing services, disease prevention solutions, and at-home drug delivery services.
1929
24.8K+
LTM Revenue $6.2B
LTM EBITDA $411M
$3.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Tsuruha Holdings has a last 12-month revenue (LTM) of $6.2B and a last 12-month EBITDA of $411M.
In the most recent fiscal year, Tsuruha Holdings achieved revenue of $5.8B and an EBITDA of $311M.
Tsuruha Holdings expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Tsuruha Holdings valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $6.2B | XXX | $5.8B | XXX | XXX | XXX |
| Gross Profit | $1.9B | XXX | $1.8B | XXX | XXX | XXX |
| Gross Margin | 30% | XXX | 30% | XXX | XXX | XXX |
| EBITDA | $411M | XXX | $311M | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | 5% | XXX | XXX | XXX |
| EBIT | $284M | XXX | $260M | XXX | XXX | XXX |
| EBIT Margin | 5% | XXX | 4% | XXX | XXX | XXX |
| Net Profit | $134M | XXX | $118M | XXX | XXX | XXX |
| Net Margin | 2% | XXX | 2% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Tsuruha Holdings's stock price is JPY 11305 (or $78).
Tsuruha Holdings has current market cap of JPY 550B (or $3.8B), and EV of JPY 521B (or $3.6B).
See Tsuruha Holdings trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.6B | $3.8B | XXX | XXX | XXX | XXX | $2.76 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Tsuruha Holdings has market cap of $3.8B and EV of $3.6B.
Tsuruha Holdings's trades at 0.6x EV/Revenue multiple, and 10.9x EV/EBITDA.
Equity research analysts estimate Tsuruha Holdings's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Tsuruha Holdings has a P/E ratio of 28.1x.
See valuation multiples for Tsuruha Holdings and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3.8B | XXX | $3.8B | XXX | XXX | XXX |
| EV (current) | $3.6B | XXX | $3.6B | XXX | XXX | XXX |
| EV/Revenue | 0.6x | XXX | 0.6x | XXX | XXX | XXX |
| EV/EBITDA | 8.7x | XXX | 10.9x | XXX | XXX | XXX |
| EV/EBIT | 12.6x | XXX | 13.1x | XXX | XXX | XXX |
| EV/Gross Profit | 1.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | 28.1x | XXX | 30.0x | XXX | XXX | XXX |
| EV/FCF | 16.0x | XXX | 13.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialTsuruha Holdings's last 12 month revenue growth is 22%
Tsuruha Holdings's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Tsuruha Holdings's rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Tsuruha Holdings's rule of X is 62% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Tsuruha Holdings and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 22% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Growth | 19% | XXX | 24% | XXX | XXX | XXX |
| Rule of 40 | 28% | XXX | 28% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 62% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 26% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| SC Ropharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Tsuruha Holdings acquired XXX companies to date.
Last acquisition by Tsuruha Holdings was XXXXXXXX, XXXXX XXXXX XXXXXX . Tsuruha Holdings acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Tsuruha Holdings founded? | Tsuruha Holdings was founded in 1929. |
| Where is Tsuruha Holdings headquartered? | Tsuruha Holdings is headquartered in Japan. |
| How many employees does Tsuruha Holdings have? | As of today, Tsuruha Holdings has 24.8K+ employees. |
| Who is the CEO of Tsuruha Holdings? | Tsuruha Holdings's CEO is Mr. Jun Tsuruha. |
| Is Tsuruha Holdings publicy listed? | Yes, Tsuruha Holdings is a public company listed on TKS. |
| What is the stock symbol of Tsuruha Holdings? | Tsuruha Holdings trades under 3391 ticker. |
| When did Tsuruha Holdings go public? | Tsuruha Holdings went public in 2005. |
| Who are competitors of Tsuruha Holdings? | Similar companies to Tsuruha Holdings include e.g. MedPlus India, SC Ropharma, Pague Menos, Droga Raia. |
| What is the current market cap of Tsuruha Holdings? | Tsuruha Holdings's current market cap is $3.8B |
| What is the current revenue of Tsuruha Holdings? | Tsuruha Holdings's last 12 months revenue is $6.2B. |
| What is the current revenue growth of Tsuruha Holdings? | Tsuruha Holdings revenue growth (NTM/LTM) is 22%. |
| What is the current EV/Revenue multiple of Tsuruha Holdings? | Current revenue multiple of Tsuruha Holdings is 0.6x. |
| Is Tsuruha Holdings profitable? | Yes, Tsuruha Holdings is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Tsuruha Holdings? | Tsuruha Holdings's last 12 months EBITDA is $411M. |
| What is Tsuruha Holdings's EBITDA margin? | Tsuruha Holdings's last 12 months EBITDA margin is 7%. |
| What is the current EV/EBITDA multiple of Tsuruha Holdings? | Current EBITDA multiple of Tsuruha Holdings is 8.7x. |
| What is the current FCF of Tsuruha Holdings? | Tsuruha Holdings's last 12 months FCF is $223M. |
| What is Tsuruha Holdings's FCF margin? | Tsuruha Holdings's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of Tsuruha Holdings? | Current FCF multiple of Tsuruha Holdings is 16.0x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
